Evidence map›Paper›PMID 36992906›Full record

ReviewFrontiers in nutrition2023

Analysis of the active ingredients and health applications of cistanche.

Shiqi Zhou, Duo Feng, Yaxi Zhou, Hao Duan, Yongjun Jiang, Wenjie Yan

Full text readReview
In one paragraph

Review in Frontiers in nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Frontiers in pharmacology · 2026
    Trial
  3. Effects ofNutrients · 2025
    Trial
  4. Nutrients · 2026
    Article
  5. Review
  6. Neuropsychiatric disease and treatment · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Quality evaluation ofFrontiers in nutrition · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shiqi ZhouCollege of Biochemical Engineering, Beijing Union University, Beijing, China.
Duo FengCollege of Biochemical Engineering, Beijing Union University, Beijing, China.
Yaxi ZhouCollege of Biochemical Engineering, Beijing Union University, Beijing, China.
Hao DuanCollege of Biochemical Engineering, Beijing Union University, Beijing, China.
Yongjun JiangInner Mongolia Sankou Biotechnology Co., Ltd., Ordos City, Inner Mongolia, China.
Wenjie YanCollege of Biochemical Engineering, Beijing Union University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cistanche is a tonic Chinese medicine commonly used in traditional Chinese medicine, with 2016, CFSA through the alxa desert cistanche safety evaluation, cistanche began to officially enter the food field. At present, the research on cistanche mainly focuses on the extraction, isolation and purification and pharmacological effects, and its pharmacological effects such as neuroprotective effects, immunomodulation, antioxidant anticancer and hepatoprotective liver protection have attracted the attention of researchers. This review mainly reviews the research status, chemical composition and health benefits, analyzes its application prospects in food, and aims to provide certain theoretical support for the safe application of cistanche in functional food.

Indexed as

active ingredientCistanchehealth benefitshomology of medicine and foodPHG

Identifiers

PMID36992906
PMCPMC10042234

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read39
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.